Publication | Open Access

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab

MedicineColorectal CancerPathologyCancer GenomicsEgfr Gene GainCancer GeneticsOncologyCell BiologyTumor BiologyFavorable Prognostic Factors